Application of fructus lycii as medicine for preventing and treating immunological liver injury

The invention relates to the technical field of traditional Chinese medicine application, and discloses application of Chinese wolfberry as a medicine for preventing and treating immunological liver injury. The application comprises the following steps: A) application of Chinese wolfberry in prepari...

Full description

Saved in:
Bibliographic Details
Main Authors LI HANGYING, WANG JIEXIN, QI JIAMIN, YANG WEI, ZHENG JIE, ZHANG LIMING
Format Patent
LanguageChinese
English
Published 25.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to the technical field of traditional Chinese medicine application, and discloses application of Chinese wolfberry as a medicine for preventing and treating immunological liver injury. The application comprises the following steps: A) application of Chinese wolfberry in preparing the medicine for treating immunological liver injury; b) application of fructus lycii in preparation of a medicine for reducing inflammatory factors in serum; and C) application of wolfberry in preparation of a product for reducing oxidative stress level. The wolfberry glycopeptides can improve the levels of AST and ALT transaminase in serum, improve and repair the damage of liver tissues, and improve the levels and contents of MDA, SOD and GSH-PX in oxidative stress indexes to different degrees; the content of inflammatory factors TNF-alpha, I FN-gamma and I L-1beta in mouse serum is reduced, dynamic immune disorder in liver injury is effectively regulated, and occurrence and development of the disease are impr
Bibliography:Application Number: CN202410365004